| Imaging tumor-stroma interactions during chemotherapy reveals contributions of the microenvironment to resistance ES Nakasone, HA Askautrud, T Kees, JH Park, V Plaks, AJ Ewald, M Fein, ... Cancer cell 21 (4), 488-503, 2012 | 517 | 2012 |
| Recent endemic coronavirus infection is associated with less-severe COVID-19 M Sagar, K Reifler, M Rossi, NS Miller, P Sinha, LF White, JP Mizgerd The Journal of clinical investigation 131 (1), 2021 | 306 | 2021 |
| Undernutrition and tuberculosis: public health implications P Sinha, J Davis, L Saag, C Wanke, P Salgame, J Mesick, ... The Journal of infectious diseases 219 (9), 1356-1363, 2019 | 146 | 2019 |
| Early administration of interleukin-6 inhibitors for patients with severe COVID-19 disease is associated with decreased intubation, reduced mortality, and increased discharge P Sinha, A Mostaghim, CG Bielick, A McLaughlin, DH Hamer, LM Wetzler, ... International Journal of Infectious Diseases 99, 28-33, 2020 | 81 | 2020 |
| Food for thought: addressing undernutrition to end tuberculosis P Sinha, K Lönnroth, A Bhargava, SK Heysell, S Sarkar, P Salgame, ... The Lancet Infectious Diseases 21 (10), e318-e325, 2021 | 62 | 2021 |
| Why do doctors commit suicide P Sinha The New York Times 4, 2014 | 57 | 2014 |
| Cost effectiveness of caplacizumab in acquired thrombotic thrombocytopenic purpura G Goshua, P Sinha, JE Hendrickson, C Tormey, PK Bendapudi, AI Lee Blood, The Journal of the American Society of Hematology 137 (7), 969-976, 2021 | 48 | 2021 |
| Undernutrition is feeding the tuberculosis pandemic: a perspective ME Carwile, NS Hochberg, P Sinha Journal of Clinical Tuberculosis and Other Mycobacterial Diseases 27, 100311, 2022 | 32 | 2022 |
| Clinical outcomes and inflammatory marker levels in patients with Covid-19 and obesity at an inner-city safety net hospital A Mostaghim, P Sinha, C Bielick, S Knudsen, I Beeram, LF White, ... PLoS One 15 (12), e0243888, 2020 | 27 | 2020 |
| A novel interprofessional approach to end-of-life care education: A pilot study P Sinha, SP Murphy, CM Becker, HJ Poarch, KE Gade, AT Wolf, ... Journal of interprofessional care 29 (6), 643-645, 2015 | 21 | 2015 |
| Cost‐effectiveness of aducanumab to prevent Alzheimer's disease progression at current list price P Sinha, JA Barocas Alzheimer's & Dementia: Translational Research & Clinical Interventions 8 (1 …, 2022 | 19 | 2022 |
| Combination therapy with tocilizumab and dexamethasone cost-effectively reduces Coronavirus disease 2019 mortality P Sinha, BP Linas Clinical Infectious Diseases 73 (11), 2116-2118, 2021 | 19 | 2021 |
| How much do Indians pay for tuberculosis treatment? A cost analysis P Sinha, M Carwile, A Bhargava, C Cintron, C Acuna-Villaorduna, ... Public Health Action 10 (3), 110-117, 2020 | 19 | 2020 |
| Opportunities for community health workers to contribute to global efforts to end tuberculosis P Sinha, SV Shenoi, GH Friedland Global public health 15 (3), 474-484, 2020 | 18 | 2020 |
| Impact of undernutrition on tuberculosis treatment outcomes in India: a multicenter, prospective, cohort analysis P Sinha, C Ponnuraja, N Gupte, S Prakash Babu, SR Cox, S Sarkar, ... Clinical Infectious Diseases 76 (8), 1483-1491, 2023 | 15 | 2023 |
| Nutritional supplementation would be cost-effective for reducing tuberculosis incidence and mortality in India: the Ration Optimization to Impede Tuberculosis (ROTI-TB) model P Sinha, SL Lakshminarayanan, C Cintron, PB Narasimhan, LM Locks, ... Clinical Infectious Diseases 75 (4), 577-585, 2022 | 14 | 2022 |
| Coronavirus disease 2019 mitigation strategies were associated with decreases in other respiratory virus infections P Sinha, K Reifler, M Rossi, M Sagar Open forum infectious diseases 8 (6), ofab105, 2021 | 13 | 2021 |
| Malnutrition leads to increased inflammation and expression of tuberculosis risk signatures in recently exposed household contacts of pulmonary tuberculosis A VanValkenburg, V Kaipilyawar, S Sarkar, S Lakshminarayanan, ... Frontiers in immunology 13, 1011166, 2022 | 11 | 2022 |
| Synergism between diabetes and human immunodeficiency virus in increasing the risk of tuberculosis P Sinha, AP Moll, RP Brooks, YH Deng, SV Shenoi The International Journal of Tuberculosis and Lung Disease 22 (7), 793-799, 2018 | 11 | 2018 |
| Cost‐effectiveness of second‐line therapies in adults with chronic immune thrombocytopenia G Goshua, P Sinha, N Kunst, L Pischel, AI Lee, A Cuker American journal of hematology 98 (1), 122-130, 2023 | 10 | 2023 |
Natasha HochbergBoston University School of MedicineVerified email at bu.edu
